Close
Practical Applications of New Agents in Oncology
Saturday, February 17, 2024
to
Sunday, February 18, 2024
Register today
-
About
About This Event
Join us for the 26th annual Practical Applications of New Agents in Oncology (PANAO), a nationally recognized conference for health care professionals interested in learning about new anticancer agents and treatments. The nationally recognized speakers presenting at this conference will discuss the advances in agents and the therapeutic paradigms that overlap in different disease specialties.
Hematology and medical oncology physicians, researchers, fellows, residents, nurse practitioners, physician assistants, registered nurses, pharmacists, and clinical research coordinators are invited to attend.
Topics will include:
- Drug development in epigenetic regulation
- Gene therapy
- Novel Drug Development in Oncology
It is a continuing education (CME) activity designed for healthcare professionals specializing in oncology and hematology. The University of Texas Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas Health Science Center San Antonio designates this live activity AMA PRA Category 1 Credits™.
Payments are accepted by credit and/or debit cards ONLY.
See the photos from the PANAO 2023 symposium!
-
Agenda
Agenda
Saturday, February 17, 2024 Time Session 7:30-8:15 a.m. Registration and breakfast 8:15-8:20 a.m. Opening remarks
Daruka Mahadevan, MD, PhD
Mays Cancer Center at UT Health San Antonio8:20-10:25 a.m. Session 1: New drugs in oncology Moderator:
John Sarantopoulos, MD
Mays Cancer Center at UT Health San Antonio8:20-9:00 a.m. Overview of Novel Drug Development in Oncology
Andrew Brenner, MD
Mays Cancer Center at UT Health San Antonio9:00-9:30 a.m. KRAS inhibitors and pancreatic cancer-The Time is Now Shubham Pant, MD
MD Anderson Cancer Center9:30-10:00 a.m. Emerging non-TKI Targeted Therapies in NSCLC Jia Luo, MD
Dana Faber Cancer Institute10:00-10:10 a.m. Q&A session 10:10-10:25 a.m. Break, networking and exhibition 10:25-11:35 a.m. Session 2: New drugs in Oncology Moderator:
Devi Meyyappan, MD
Mays Cancer Center at UT Health San Antonio10:25-10:55 a.m. Drug Development in Colorectal Cancers Anna Capasso, MD, PhD
University of Texas at Austin10:55-11:25 a.m. Novel Therapies in Thoracic Malignancies including ADC, bi-specifics, and CAR T Bingnan Zhang, MD, PhD
MD Anderson Cancer Center11:25-11:35 a.m. Q&A session 11:35 a.m. -1:00 p.m. Lunch, networking and exhibition 1:00-4:00 p.m. Session 3: New drugs in Hematology Moderator:
Matthew Butler, MD
Mays Cancer Center at UT Health San AntonioJohn Sarantopoulos, MD
Mays Cancer Center at UT Health San Antonio1:00-1:40 p.m. Overview of New Drugs in Classical Hematology Usha Perepu, MD
Mays Cancer Center at UT Health San Antonio1:40-2:10 p.m. Therapeautic Accomplishments in Hemophilia Deanna Maida, MD
Mays Cancer Center at UT Health San Antonio2:10-2:40 p.m. Advances and CAR T-cell therapy in Future Directions in Lymphoma Sattva Neelapu, MD
MD Anderson Cancer Center2:40-2:50 p.m. Break, networking and exhibition 2:50-3:20 p.m. Targeting Protein Homeostasis in Acute Myeloid Leukemia Kevin Kelly, MD
University of South California3:20-3:50 p.m. Promising Drugs in Early Phase Trials in Multiple Myeloma Leon Bernal-Mizrachi, MD
Emory University3:50-4:20 p.m. Novel Agents in Combinations in Urothelial Cancer Chethan Ramamurthy, MD
Merck4:20-4:30 p.m. Q&A 4:30 p.m. Adjourn Sunday, February 18, 2024 Time Session 7:15-8:15 a.m. Registration and breakfast 8:15-11:10 a.m. Session 4: Drug Development and Translational Research Moderator:
Daruka Mahadevan, MD, PhD
Mays Cancer Center at UT Health San Antonio8:15-8:45 a.m. Drug and Research Development in HR repair Patrick Sung, PhD
Mays Cancer Center at UT Health San Antonio8:45-9:15 a.m. Non-Homologous End Joining (NHEJ) DNA Repair Targeted Therapies in Development Daruka Mahadevan, PhD
Mays Cancer Center at UT Health San Antonio9:15-9:25 a.m. Break, networking and exhibition 9:25-9:55 a.m. Towards Clinical Trial Target AXL-Stat 3 Signaling in Lung Tumor Microenvironments Josephine Taverna, MD
Mays Cancer Center at UT Health San Antonio9:55-10:25 a.m. Translational Research (Investigator initiated trials) Daohong Zhou, MD
Mays Cancer Center at UT Health San Antonio10:25-10:55 a.m. Updates in Immune Therapy for Breast Cancer Heather McArthur, MD
UT Southwester10:55-11:10 a.m. Q&A 11:10 a.m. – 12:20 p.m. Session 5: Case Studies in Molecular Targeted Treatment of Cancer Moderators:
Jeanne Kowalski, PhD
UT Dell Medical School
Devi Meyyappan, MD
Mays Cancer Center at UT Health San Antonio11:10-11:40 a.m. My Cancer Molecular Information Exchange:
Building a patient-centric molecular treatment data fabric for clinical decision supportJeanne Kowalski, PhD
UT Dell Medical School11:40-11:55 a.m. HER2 Negative Stomach Adenocarcinoma Anna Capasso, MD
University of Texas at Austin11:55 a.m.-12:10 p.m. mEGFR SCLC Tamarah Aldawood, MD
UT Health San Antonio12:10-12:20 p.m. Q&A 12:20-1:20 p.m. Lunch, networking and exhibition 1:20-2:10 p.m. Session 6: Clinical trials Moderator:
John Sarantopoulos, MD
Mays Cancer Center at UT Health San Antonio1:20-1:35 p.m. Targeting Chemotherapy-Induced Polyploidy, a known mechanism of therapeutic resistance Moderator:
Patrick Conway, PhD
UT Health San Antonio1:35-1:55 p.m. Patient Navigation in Clinical Trials Leslie Villarreal, RN
Mays Cancer Center at UT Health San Antonio1:55-2:05 p.m. Q&A
Award presentation
2:05-2:10 p.m. Closing remarks
John Sarantopoulos, MD,
Mays Cancer Center at UT Health San Antonio -
Date and Time
Date and Time
- Saturday, February 17, 2024, 7:00AM
- to Sunday, February 18, 2024, 6:00PM
-
Location
Location
-
Contact
Contact
For questions or inquiries about this event, please contact Brittany Taylor.
For questions or inquiries about exhibiting, please contact Hugo Flores.
-
Exhibitor Details
Exhibitor Details
All-day beverages, breakfast and lunch will be placed in the same room as the exhibits. Exhibit hours will be Saturday, Feb. 17, 7:00 a.m. – 5:30 p.m. and Sunday, Feb. 18, from 7:00 a.m. – 4:30 p.m. Exhibitors are welcome to display until 5:00 p.m. on Sunday. Gamification will be used to encourage interaction between the exhibitors and attendees.
Exhibitors will receive a 6-foot by 3-foot table, which gives full access to the meeting and two exhibit staff, a value of $900, or sponsorship in any amount, that will help defray the reasonable costs associated with non-educational expenses.
Submit your exhibit and support request by February 1, 2024.